Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;178(1):79-85.
doi: 10.1007/s10517-024-06286-7. Epub 2024 Nov 22.

Polymorphisms of ANPEP Gene Are Associated with Microvascular Complications of Type 2 Diabetes

Ya E Korvyakova  1 , I E Azarova  2 , D D Markina  1 , M I Churilin  1 , O Yu Bushueva  1 , E Yu Klyosova  1 , M A Solodilova  1 , A V Polonikov  1
Affiliations

Polymorphisms of ANPEP Gene Are Associated with Microvascular Complications of Type 2 Diabetes

Ya E Korvyakova et al. Bull Exp Biol Med. 2024 Nov.

Abstract

We studied the association of polymorphisms in the aminopeptidase N gene (ANPEP) with the development of diabetic retinopathy and nephropathy in patients with type 2 diabetes mellitus (T2DM). DNA samples from T2DM patients (n=1425) were genotyped for 23 single nucleotide polymorphisms (SNPs) using the MassARRAY system. Associations of SNP rs13380049 of the ANPEP gene with a lower risk of diabetic retinopathy (OR=0.54, 95%CI 0.36-0.82, p=0.0032) and nephropathy (OR=0.66, 95%CI 0.44-0.99, p=0.048) were found in T2DM patients. In addition, SNP rs25653 was associated with retinopathy, and polymorphisms rs6496608, rs72756574, rs9920421, and rs4932143 were associated with diabetic nephropathy. The study demonstrated the contribution of ANPEP gene polymorphisms in the determination of microvascular complications in T2DM patients.

Keywords: ANPEP; diabetic nephropathy; diabetic retinopathy; genetic predisposition; type 2 diabetes mellitus.

PubMed Disclaimer

References

    1. Ding L, Fan L, Xu X, Fu J, Xue Y. Identification of core genes and pathways in type 2 diabetes mellitus by bioinformatics analysis. Mol. Med. Rep. 2019;20(3):2597-2608. https://doi.org/10.3892/mmr.2019.10522 - DOI - PubMed - PMC
    1. Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, Yengo L, Lloyd-Jones LR, Sidorenko J, Wu Y; eQTLGen Consortium; McRae AF, Visscher PM, Zeng J, Yang J. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat. Commun. 2018;9(1):2941. https://doi.org/10.1038/s41467-018-04951-w
    1. World Health Organization. Global report on diabetes: executive summary. WHO/NMH/NVI/16.3, 21 October 2016. URL: https://www.who.int/publications/i/item/who-nmh-nvi-16.3
    1. Dedov II, Shestakova MV, Mayorov AYu, Mokrysheva NG, Andreeva EN, Bezlepkina OB, Peterkova VA, Artemova EV, Bardiugov PS, Beshlieva DD, Bondarenko ON, Burumkulova FF, Vikulova OK, Volevodz NN, Galstyan GR, Gomova IS, Grigoryan OR, Dzhemilova ZN, Ibragimova LI, Kalashnikov VYu, Kononenko IV, Kuraeva TL, Laptev DN, Lipatov DV, Melnikova OG, Mikhina MS, Michurova MS, Motovilin OG, Nikonova TV, Rozhivanov RV, Smirnova OM, Starostina EG, Surkova EV, Sukhareva OYu, Tiselko AV, Tokmakova AYu, Shamkhalova MSh, Shestakova EA, Jarek-Martynowa IYa, Yaroslavceva MV. Standards of specialized diabetes care. Dedov II, Shestakova MV, Mayorov AYu, eds. 11th edition. Sakharny Diabet. 2023;26(Suppl. 2):1-157. Russian. https://doi.org/10.14341/DM13042
    1. Klyosova EYu, Azarova IuE, Sunyaykina OA, Polonikov AV. Validity of a brief screener for environmental risk factors of age-related diseases using type 2 diabetes and coronary artery disease as examples. Nauch. Rez. Biomed. Issled. 2022;8(1):130-138. Russian. https://doi.org/10.18413/2658-6533-2022-8-1-0-10

LinkOut - more resources